News and research | Latest news about liver disease

Patient reviewing test documentation with a healthcare provider.

Featured Post

From inception to practice— new insights from the development of a high-performance liquid biopsy test for the detection of early-stage HCC

Continuing the rigorous clinical evaluation of the blood-based tests for use in HCC surveillance, researchers conducted an additional performance analysis...

Learn More

From inception to practice— new insights from the development of a high-performance liquid biopsy test for the detection of early-stage HCC
HCC surveillance: common goals, collective impact
Evaluating an ALTernative to UltraSound: the ALTUS study for the surveillance of HCC
The COVID-19 pandemic reveals an opportunity to optimize the surveillance of HCC
Hepatocellular carcinoma in the United States—HCV infection remains a threat, even as NAFLD increases
Improved Surveillance Is Urgently Needed to Help Reduce the Burden of Hepatocellular Carcinoma
A simple blood test may detect HCC in its early stages, potentially improving patient outcomes
Hepatocellular carcinoma is 10 times more likely to develop in the setting of nonalcoholic steatohepatitis than in simple fatty liver disease
Chronic liver disease is often a precursor to hepatocellular carcinoma
Early-stage hepatocellular carcinoma can be challenging to detect—it doesn’t have to be
We can improve hepatocellular carcinoma surveillance by understanding how risk factors are changing
Hepatocellular carcinoma has a high mortality rate—Improved surveillance may help reduce it

Oncoguard^® Liver solution

Quick Links

Oncoguard® Liver solution

Quick Links

Follow us on

Oncoguard^® Liver solution